Maria Martinez Colon, MD
Dermatology · San Juan, PRNPI 1073554390
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,098 of the $5,723 with a category attached, or 71.6%. AbbVie accounts for 68.2% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $2,752, more than ten times the $134 reported in 2019.
Across 61 payments — averaging $93.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- E.r. Squibb & Sons, L.L.C.$743
- Amgen$359
- Lilly USA, LLC$312
- Sun Pharmaceutical Industries Inc.$244
- Pfizer$138
- plus $24 from 1 others
Across 486 payments — averaging $2970.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1.3M
- Eli Lilly Export S.A. Puerto Rico Branch$75K
- Amgen$24K
- Pfizer$6K
- Eli Lilly$3K
What the payments were for
- Consulting fees$1,57528%
- Food & beverage$4,09872%
- Education$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $3,903 |
| E.r. Squibb & Sons, L.L.C. | 9 | $743 |
| Amgen | 5 | $359 |
| Lilly USA, LLC | 3 | $312 |
| Sun Pharmaceutical Industries Inc. | 2 | $244 |
| Pfizer | 3 | $138 |
| AstraZeneca | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,723 in reported general payments places this provider in the 80th percentile of 108 dermatology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Dipropionate | 190 | $7,562 |
| Pimecrolimus | 27 | $3,660 |
| Desonide | 74 | $3,184 |
| Metronidazole | 38 | $3,109 |
| Dutasteride | 69 | $2,851 |
| Mometasone Furoate | 77 | $2,026 |
| Clobetasol Propionate | 62 | $1,995 |
| Ketoconazole | 86 | $1,880 |
| Imiquimod | 43 | $1,258 |
| Doxycycline Hyclate | 55 | $888 |
| Minoxidil | 39 | $883 |
| Levocetirizine Dihydrochloride | 59 | $832 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 12 | $636 |
| Terbinafine Hcl | 13 | $219 |
| Mupirocin | 23 | $214 |
Paid to pharmacies, not to this prescriber.
Other dermatology in San Juan
- Jose Gonzalez ChavezSan Juan$248K
- Rafael Martin GarciaSan Juan$199K
- Noelani Gonzalez-OrtizSan Juan$154K
- Elena Montalvan MiroSan Juan$20K
- Damaris Torres PaoliSan Juan$6K
- Natalia Pelet del ToroSan Juan$5K
- Frances HernandezSan Juan$5K
- Karina Cancel ArtauSan Juan$4K
- Eduardo Michelen GomezSan Juan$4K
- Andrea CaroSan Juan$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.